Harrow

HROWM

Tags: US Healthcare Medical - Pharmaceuticals

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price (HROWM)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

32,616,777

(18.775)%

Market Cap of Harrow (HROWM)

Market cap:

As of , HROWM has a market cap of . This makes HROWM the 2119th most valuable company in the US by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $25.3-27.7
Market Cap 825.89M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Pharmaceuticals

ceo: Mark L. Baum
IPO Date: December, 29, 2022
Country: US
Currency: USD
Headquaters: No Data
Employees: 217

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: